IL-33 promotes DC development in BM culture by triggering GM-CSF production

Nobuyasu Mayuzumi1, Hironori Matsushima, Akira Takashima

  • 1Department of Medical Microbiology and Immunology, University of Toledo College of Medicine, Toledo, OH 43614-5806, USA.

Insights

Interleukin-33 (IL-33) enhances dendritic cell (DC) generation in bone marrow cultures indirectly by increasing granulocyte-macrophage colony-stimulating factor (GM-CSF) production. This reveals a novel pathway supporting DC development.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Dendritic cell (DC) immunobiology research benefits from short-term cultures using cytokines like granulocyte-macrophage colony-stimulating factor (GM-CSF).
  • Understanding factors that regulate DC development is crucial for immunology research.

Purpose of the Study:

  • To screen a panel of 65 cytokines for their ability to promote CD11c+ cell generation in murine bone marrow (BM) cultures.
  • To investigate the mechanism by which IL-33 influences DC development.

Main Methods:

  • Murine BM cultures were treated with individual cytokines.
  • Flow cytometry was used to analyze CD11c+ cell populations and their surface marker expression (MHC class II, PD-L1, PD-L2).
  • Responses to Toll-like receptor (TLR) ligands, IL-12 p70 production, T cell activation, and GM-CSF levels were assessed.

Main Results:

  • IL-33 significantly augmented CD11c+ cell generation in a dose- and time-dependent manner.
  • The CD11c+ cells generated with IL-33 showed typical dendritic morphology but had modest MHC class II expression and poor responses to TLR ligands.
  • IL-33 treatment increased GM-CSF mRNA and protein in BM cultures, an effect blocked by anti-GM-CSF antibody, indicating indirect DC generation via GM-CSF.
  • IL-33-dependent GM-CSF production was localized to the CD45+/FcepsilonRI+ BM cell population.

Conclusions:

  • IL-33 promotes in vitro dendritic cell generation indirectly through a GM-CSF-dependent mechanism.
  • This study identifies a novel pathway involving IL-33 that supports dendritic cell development.
  • GM-CSF remains a primary growth factor for dendritic cells, with IL-33 acting upstream to stimulate its production.